Amphastar Pharmaceuticals
(NASDAQ) AMPH
Amphastar Pharmaceuticals Financials at a Glance
Market Cap
$861.13M
Revenue (TTM)
$720.53M
Net Income (TTM)
$79.23M
EPS (TTM)
$1.66
P/E Ratio
11.73
Dividend
$0.00
Beta (Volatility)
0.60 (Low)
Dividend
$0.00
Beta (Volatility)
0.60 (Low)
Price
$21.02
Volume
21,909
Open
$20.00
Price
$21.02
Volume
21,909
Open
$20.00
Previous Close
$21.02
Daily Range
$19.97 - $21.10
52-Week Range
$16.65 - $31.26
Estimated Earnings Date
Aug 6, 2026
Dividend
$0.00
Beta (Volatility)
0.60 (Low)
Price
$21.02
Volume
21,909
Open
$20.00
Previous Close
$21.02
Daily Range
$19.97 - $21.10
52-Week Range
$16.65 - $31.26
Estimated Earnings Date
Aug 6, 2026
AMPH News
AMPH: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Amphastar Pharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareEmployees
1,976
CEO
Yong Feng Zhang, PhD
Website
www.amphastar.comHeadquarters
Rancho Cucamonga, CA 91730, US
AMPH Financials
Key Financial Metrics (TTM)
Gross Margin
47.34%
Operating Margin
16.20%
Net Income Margin
11.00%
Return on Equity
10.23%
Return on Capital
9.72%
Return on Assets
4.81%
Earnings Yield
8.53%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$861.13M
Shares Outstanding
44.09M
Volume
21.91K
Avg. Volume
604.06K
Financials (TTM)
Gross Profit
$341.13M
Operating Income
$116.74M
EBITDA
$191.41M
Operating Cash Flow
$168.88M
Capital Expenditure
-$33.69M
Free Cash Flow
$135.19M
Cash & ST Invst.
$294.39M
Total Debt
$686.38M
Amphastar Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$171.17M
+0.4%
Gross Profit
$70.32M
-17.5%
Gross Margin
41.08%
N/A
Market Cap
$861.13M
N/A
Market Cap/Employee
$424.62K
N/A
Employees
2,028
N/A
Net Income
$6.42M
-74.6%
EBITDA
$33.10M
-36.8%
Quarterly Fundamentals
Total Cash
$294.39M
+24.3%
Total Debt
$686.38M
+5.2%
Accounts Receivable
$147.85M
+1.7%
Inventory
$170.19M
-8.2%
Long Term Debt
$675.00M
+4.7%
Short Term Debt
$11.38M
+42.7%
Return on Assets
4.81%
N/A
Return on Invested Capital
7.87%
N/A
Free Cash Flow
$38.33M
+57.2%
Operating Cash Flow
$47.84M
+36.4%